DeltaHealth Hospital Shanghai Celebrates 1st Anniversary and New Model Promotes its Fast Development in China

SHANGHAI, Sept. 8, 2017 /PRNewswire/ -- Today, DeltaHealth Hospital Shanghai - the foreign-invested general hospital in China that specializes in cardiovascular care - celebrated its first anniversary. "China is struggling with a rising incidence of cardiovascular diseases and certain critical diseases are extremely demanding of clinical skills. As a foreign-invested hospital, DeltaHealth HospitalShanghai courageously focuses on cardiovascular care as a direct response to the needs of Chinese patients, which leads the direction for the social capital to invest in healthcare," said Mr. Huaiqiong Zhang at the anniversary ceremony, Deputy Director of Shanghai Municipal Commission of Health and Family Planning.

DeltaHealth initiated the Advisory Board on Transcatheter Aortic Valve Implantation (TAVI)
DeltaHealth initiated the Advisory Board on Transcatheter Aortic Valve Implantation (TAVI)

Since its inception, DeltaHealth HospitalShanghai has been providing seamless, integrated care solutions ranging from screening to diagnosis, treatment, recovery and nutrition in a multi-disciplinary and cross-departmental approach. One Heart Team model has demonstrated excellence in the performance of the over 200 cardiovascular surgeries. "From the moment the patient enters the hospital, we can mobilize internal resources within the shortest possible time to focus on the patient. We are comparable to the world's leading hospitals in terms of mortality, incidence of complications, time of ex-tubation and recovery speed," said Prof. Li Zhong Sun, President & Chief Medical Officer of DeltaHealth Hospital Shanghai. Of the more than 200 cardiovascular surgeries performed by DeltaHealth Hospital, over 50% are highly intractable, complicated and interventional surgical operations.

At the anniversary, DeltaHealth also held the meeting to initiate the Advisory Board on Transcatheter Aortic Valve Implantation (TAVI), which is co-chaired by Prof. Lizhong Sun and Academician Junbo Ge, Chief Medical Officer, Cardiology of DeltaHealth Hospital Shanghai. As the strategic partner of DeltaHealth HospitalShanghai, Columbia HeartSource will act as the senior advisory team of the committee. "TAVI surgery has been widely adopted globally, but China has a long way to go in this regard. I'm full of expectations for the TAVI Advisory Board of DeltaHealth Hospital, which is supported by clinically experienced senior advisors from Columbia HeartSource. I hope this surgery will benefit more Chinese patients in the future," said Academician Junbo Ge. As an innovative clinical solution for patients, TAVI surgery eliminates the need of thoracotomy and provides the benefits of minimal invasiveness and fast recovery after the surgery.

"DeltaHealth can access extensive networks of medical resources locally and globally. As its only strategic partner in China, we have conducted extensive exchanges and cooperation with Columbia HeartSource over the past year. We also partner with local outstanding cardiovascular experts to hold regular high-level academic meetings to ensure the implementation of the 'Patient-Centricity' concept with the support of our exceptional clinical capabilities," said Desmond Thio MD, PhD., CEO of DeltaHealth. Just early this year, the DeltaHealth team paid a special visit to Columbia HeartSource to observe and study the clinical practice of TAVI surgery.

On the strength of its outstanding clinical expertise, highly qualified medical staff and robust management process, within only one year, DeltaHealth Hospital Shanghai has become a member of the Shanghai Medical Association, the Shanghai Medical Doctor Association, the Shanghai Nursing Association and the Shanghai Association for Non-Government Medical Institutions. "Healthcare is a special cause. Since we prepared to establish the hospital, we have been guided by a long-term view. Thanks to the strong leadership of the management team, we have achieved satisfactory progress in various fields," said Daniel Auerbach, Chairman of the Board of DeltaHealth.

Apart from strengthening the clinical development of cardiology, DeltaHealth has also established its social responsibility as one of its foremost priorities. One of its social programs, the DeltaHealth Heart Charity Fund, is committed to building public awareness of cardiovascular health, offer charitable aid and promote academic exchanges and research in China. To date, the Fund has offered aid worth more than RMB 8 million to over 80 patients in need of surgery. Besides, nearly 600 people have also benefited from pro bono diagnostic and counselling services provided by DeltaHealth HospitalShanghai in local communities over the past year.

DeltaHealth Hospital Shanghai

DeltaHealth Hospital·Shanghai, a subsidiary of DeltaHealth, a foreign-invested innovative healthcare provider, is a cardiovascular-focused general hospital designed and constructed in accordance with Joint Commission International (JCI) standards. The hospital provides internationally-standardized, high-quality medical care, and is the only Chinese medical institution to establish a consultation and advisory relationship with Columbia HeartSource. DeltaHealth Hospital is committed to founding an integrated network of hospitals and clinics in China that specializes in cardiovascular care to benefit patients in Eastern China and beyond. The hospital occupies 50,000 square meters, with 200 beds set up in the first phase, and 350 beds planned for phase II. It has 38 intensive care units, seven operating rooms, two cardiac catheterization laboratories, and two hybrid operating rooms. To provide patients with a full range of medical care, DeltaHealth Hospital established cardiovascular care-related departments, including Cardiology, Cardiac Surgery, Interventional Radiology & Medical Imaging, as well as general departments, such as Gynecology, Pediatrics and General Practice.

Photo -